LATHAM, N.Y.--(BUSINESS WIRE)--
AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative,
minimally invasive medical devices for vascular access, peripheral
vascular disease, surgery and oncology, today announced that it will
report financial results for the third quarter of fiscal year 2018
before the market open on Thursday, March 29, 2018. The Company's
management will host a conference call at 8:00 a.m. ET the same day to
discuss the results.
To participate in the conference call, dial 1-877-407-0784 (domestic) or
1-201-689-8560 (international) and refer to the passcode 13677111.
This conference call will also be webcast and can be accessed from the
"Investors" section of the AngioDynamics website at www.angiodynamics.com.
The webcast replay of the call will be available at the same site
approximately one hour after the end of the call.
A recording of the call will also be available from 11:00 a.m. ET on
Thursday, March 29, 2018, until 11:59 p.m. ET on Thursday, April 5,
2018. To hear this recording, dial 1-844-512-2921 (domestic) or
1-412-317-6671 (international) and enter the passcode 13677111.
About AngioDynamics, Inc.
AngioDynamics, Inc. is a leading provider of innovative, minimally
invasive medical devices used by professional healthcare providers for
vascular access, surgery, peripheral vascular disease and oncology.
AngioDynamics' diverse product lines include market-leading ablation
systems, fluid management systems, vascular access products,
angiographic products and accessories drainage products, thrombolytic
products and venous products. For more information, visit www.angiodynamics.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20180227006246/en/
Michael Greiner, Executive Vice
President & CFO
Source: AngioDynamics, Inc.
News Provided by Acquire Media